Global Wealth Management Investment Advisory, Inc. Novo Cure LTD Transaction History

Global Wealth Management Investment Advisory, Inc.

$462 Million
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $5,720 - $7,441	-100 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$68.3 - $93.8 $1,707 - $2,345	25 Added 33.33%	100 $8,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $4,639 - $7,335	75 New	75 $6,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

Black Rock Inc. New York, NY

12.1M
Shares

$374 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

11.8M
Shares

$365 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

7.92M
Shares

$244 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

4.31M
Shares

$133 Million
0.01% of portfolio
Nordwand Advisors, LLC Radnor, PA

3.03M
Shares

$93.3 Million
12.67% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Wealth Management Investment Advisory, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Global Wealth Management Investment Advisory, Inc. with notifications on news.

Account